143 related articles for article (PubMed ID: 793538)
21. Chronic liver disease in transfusion-dependent thalassemia: liver iron quantitation and distribution.
De Virgiliis S; Cornacchia G; Sanna G; Argiolu F; Galanello R; Fiorelli G; Rais M; Cossu P; Bertolino F; Cao A
Acta Haematol; 1981; 65(1):32-9. PubMed ID: 6791435
[TBL] [Abstract][Full Text] [Related]
22. Serum ferritin, liver iron stores, and liver histology in children with thalassaemia.
de Virgiliis S; Sanna G; Cornacchia G; Argiolu F; Murgia V; Porcu M; Cao A
Arch Dis Child; 1980 Jan; 55(1):43-5. PubMed ID: 7377816
[TBL] [Abstract][Full Text] [Related]
23. [A liver-specific antigen in the serum of patients with liver disease].
Rosenmund A
Schweiz Med Wochenschr; 1971 Jul; 101(28):1023-6. PubMed ID: 5003908
[No Abstract] [Full Text] [Related]
24. The etiology of chronic active hepatitis in Korea.
Prince AM; Gershon RK
Yale J Biol Med; 1979; 52(2):159-67. PubMed ID: 377825
[TBL] [Abstract][Full Text] [Related]
25. Hepatic iron overload in children with sickle cell anemia on chronic transfusion therapy.
Brown K; Subramony C; May W; Megason G; Liu H; Bishop P; Walker T; Nowicki MJ
J Pediatr Hematol Oncol; 2009 May; 31(5):309-12. PubMed ID: 19415007
[TBL] [Abstract][Full Text] [Related]
26. Chronic delta hepatitis: a difficult problem for the hepatologist.
Picciotto A; Celle G
Hepatogastroenterology; 1984 Aug; 31(4):162-3. PubMed ID: 6383995
[TBL] [Abstract][Full Text] [Related]
27. Investigations on correlations between serum enzymes and histological findings in liver disease. With special reference to transaminases and urocanase.
Trip JA; van Dam J; Eibergen R; Que GS
Acta Med Scand; 1973; 193(1-2):113-8. PubMed ID: 4145127
[No Abstract] [Full Text] [Related]
28. [Hepatic pathology of liver cirrhosis and sclerosis in patients with Cooley's disease].
Beltrami CA; Nenci I
Riv Patol Clin Sper; 1969; 10(3):165-77. PubMed ID: 5403766
[No Abstract] [Full Text] [Related]
29. Iron chelation in transfusion-dependent thalassemia with chronic hepatitis.
De Virgiliis S; Cossu P; Sanna G; Frau F; Loi E; Lobrano R; Nucaro A; Toccafondi C; Cornacchia G; Loi A; Cao A
Acta Haematol; 1982; 67(1):49-56. PubMed ID: 6800202
[TBL] [Abstract][Full Text] [Related]
30. Clinical usefulness of mean platelet volume and red blood cell distribution width to platelet ratio for predicting the severity of hepatic fibrosis in chronic hepatitis B virus patients.
Karagoz E; Ulcay A; Tanoglu A; Kara M; Turhan V; Erdem H; Oncul O; Gorenek L
Eur J Gastroenterol Hepatol; 2014 Dec; 26(12):1320-4. PubMed ID: 25210777
[TBL] [Abstract][Full Text] [Related]
31. Improvement in liver pathology of patients with β-thalassemia treated with deferasirox for at least 3 years.
Deugnier Y; Turlin B; Ropert M; Cappellini MD; Porter JB; Giannone V; Zhang Y; Griffel L; Brissot P
Gastroenterology; 2011 Oct; 141(4):1202-11, 1211.e1-3. PubMed ID: 21741344
[TBL] [Abstract][Full Text] [Related]
32. [The diagnostic value of serum hyaluronic acid, 7S domain of type IV collagen and AST/ALT ratio as markers of hepatic fibrosis in chronic hepatitis B and cirrhosis patients].
Park JH; Park CK; Kim ES; Park SY; Jo CM; Tak WY; Kweon YO; Kim SK; Choi YW
Taehan Kan Hakhoe Chi; 2003 Jun; 9(2):79-88. PubMed ID: 12824747
[TBL] [Abstract][Full Text] [Related]
33. Diagnostic value of FIB-4, aspartate aminotransferase-to-platelet ratio index and liver stiffness measurement in hepatitis B virus-infected patients with persistently normal alanine aminotransferase.
Tan YW; Zhou XB; Ye Y; He C; Ge GH
World J Gastroenterol; 2017 Aug; 23(31):5746-5754. PubMed ID: 28883700
[TBL] [Abstract][Full Text] [Related]
34. Australia antigen in chronic active liver disease with cirrhosis.
Gitnick GL; Gleich GJ; Schoenfield LJ; Baggenstoss AH; Sutnick AI; Blumberg BS; London WT; Summerskill WH
Lancet; 1969 Aug; 2(7615):285-8. PubMed ID: 4184209
[No Abstract] [Full Text] [Related]
35. Transfusional iron overload: the relationship between tissue iron concentration and hepatic fibrosis in thalassaemia.
Risdon RA; Barry M; Flynn DM
J Pathol; 1975 Jun; 116(2):83-95. PubMed ID: 1151528
[TBL] [Abstract][Full Text] [Related]
36. [Relationship between the presence of Australia antigen and some clinical and humoral features of various chronic liver diseases].
Coltorti M; Del Vecchio-Blanco C; Oriani GA; Carrella M
Minerva Med; 1972 Sep; 63(62):3367-75. PubMed ID: 4626800
[No Abstract] [Full Text] [Related]
37. Liver disease in hemophiliacs: etiological and biochemical data on 159 cases from our geographical area.
Ruggiero G; Cesaro G; Mazzella C; Gaeta GB; Miraglia E; Mastrullo L; Boffa ML; Spiteri D; Schiattarella V; de Biasi R
Hepatogastroenterology; 1985 Apr; 32(2):57-60. PubMed ID: 4007763
[TBL] [Abstract][Full Text] [Related]
38. [Post-transfusional hepatitis as a complication of surgery using the heart-lung-machine in childhood].
Pandel E; Lehmann H; Schlaak M
Z Kardiol; 1976 Jan; 65(1):37-41. PubMed ID: 1246904
[TBL] [Abstract][Full Text] [Related]
39. The APRI may be enhanced by the use of the FIBROSpect II in the estimation of fibrosis in chronic hepatitis C.
Snyder N; Nguyen A; Gajula L; Soloway R; Xiao SY; Lau DT; Petersen J
Clin Chim Acta; 2007 Jun; 381(2):119-23. PubMed ID: 17442291
[TBL] [Abstract][Full Text] [Related]
40. Major risk of blood transfusion in hemolytic anemia patients.
Omar N; Salama K; Adolf S; El-Saeed GS; Abdel Ghaffar N; Ezzat N
Blood Coagul Fibrinolysis; 2011 Jun; 22(4):280-4. PubMed ID: 21508832
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
